Projects per year
Personal profile
External positions
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
Jan 1 2020 → …
Research Area Keywords
- Cancer
- Digestive Disorders
Fingerprint
Dive into the research topics where Kirk Heyne is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C. (PI), Bernicker, E. H. (Key Personnel), Darcourt, J. (Key Personnel), Heyne, K. (Key Personnel), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)
4/9/20 → …
Project: Clinical Trial
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J. (PI), Bernicker, E. H. (CoI), Chang, J. C. (CoI), Geyer, C. E. (CoI), Heyne, K. (CoI) & Niravath, P. A. (CoI)
3/6/20 → 3/5/45
Project: Non Profit
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M. (CoI), Bernicker, E. H. (CoI), Chang, J. C. (CoI), Heyne, K. (CoI), Niravath, P. A. (CoI), Singh, M. (CoI) & Zhang, J. (CoI)
3/6/20 → 3/5/45
Project: Non Profit
-
A phase III, multicenter, randomized, study of atezolizumab/placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer
Kamat, A. A. (PI), Alaniz, A. (CoI), Bernicker, E. H. (CoI), Darcourt, J. (CoI), Heyne, K. (CoI), Singh, M. (CoI), Suri, A. (CoI) & Zaid, T. (CoI)
3/13/18 → 3/12/43
Project: Non Profit
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C. (PI), Abdelrahim, M. (CoI), Bernicker, E. H. (CoI), Chang, J. C. (CoI), Heyne, K. (CoI), Niravath, P. A. (CoI), Singh, M. (CoI) & Zhang, J. (CoI)
12/8/16 → 12/7/41
Project: Non Profit
-
P-409 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023
Esmail, A., Xu, J., Burns, E., Gee, K., Wiechmann, C., Zhang, Y., Kieser, R., Gong, Z., Umoru, G., Shah, S., Sun, K., Heyne, K. & Abdelrahim, M., 2023, In: Annals of Oncology. 34, p. S156Research output: Contribution to journal › Article › peer-review
-
Transplant Oncology: An Emerging Discipline of Cancer Treatment
Abdelrahim, M., Esmail, A., Abudayyeh, A., Murakami, N., Victor, D., Kodali, S., Cheah, Y. L., Simon, C. J., Noureddin, M., Connor, A., Saharia, A., Moore, L. W., Heyne, K., Kaseb, A. O., Gaber, A. O. & Ghobrial, R. M., Nov 9 2023, In: Cancers. 15, 22, p. 5337 1 p., 5337.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
Trial in Progress: Neoadjuvant Combination Therapy of Lenvatinib Plus Transcatheter Arterial Chemoembolization (TACE) for Transplant-eligible Patients with Large HCC: Abstracts of the 15th Biennial Congress of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), 6-9 June 2023, Lyon, France.
Abdelrahim, M., Esmail, A., Saharia, A., Kodali, S., Victor, D., Heyne, K. & Ghobrial, R. M., 2023, In: HPB. 25, p. S560Research output: Contribution to journal › Article › peer-review
-
480 Impact of infections in patients with advanced or metastatic non-small cell lung cancer (NSCLC) receiving pembrolizumab-based therapies
Burns, E. A., Xu, J., Kieser, R., Muhsen, I., Shah, S., Umoru, G., Mylavarapu, C., Zhang, Y., Crenshaw, A., Sun, K., Esmail, A., Guerrero, C., Gong, Z., Gee, K., Heyne, K., Singh, M., Zhang, J., Bernicker, E. & Abdelrahim, M., Nov 1 2022, In: J Immunother Cancer. 10, Suppl 2, p. A501Research output: Contribution to journal › Article › peer-review
-
Combination of transarterial chemoembolization (TACE) and tyrosine kinase inhibitors (TKIs) compared to TACE alone as bridging therapy transplant recipients with hepatocellular carcinoma: An update. Journal of Clinical Oncology
Esmail, A., Victor, D., Kodali, S., Graviss, E. A., Nguyen, D. T., Moore, L. W., Saharia, A., McMillan, R., Fong, J. N., Uosef, A., Elshawwaf, M., Heyne, K., Ghobrial, R. M. & Abdelrahim, M., 2022, In: Journal of Clinical Oncology. 40, 16_suppl, p. e16201-e16201Research output: Contribution to journal › Article › peer-review